AJB Investment Fund II, LP (Bradley Adam James, Bradley Melinda Hodges) purchased $21K of JCTC (indirect holdings)

AJB Investment Fund II, LP purchased 7,305 indirectly-held shares of JEWETT CAMERON TRADING CO LTD (JCTC) at $2.90 across 3 trades over 2026-10-16 to 2026-10-20. Filed jointly with AJB Capital, LLC (10% owner), Bradley Adam James (10% owner) and Bradley Melinda Hodges (10% owner).

Original reporting
SEC EDGAR · AJB Investment Fund II, LP, AJB Capital, LLC, Bradley Adam James, Bradley Melinda Hodges
Published Oct 20, 2026, 9:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 9:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$JCTC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The transaction is minor and unlikely to affect price or market perception.

02

Market read

Low relevance; the filing reports a small insider purchase with minimal market impact.

03

What to watch

No material impact; the filing reflects a routine investment.

Relevance 3/10Novelty 3/10Timing: same-day filing

Background

SEC Form 4 filing discloses a $21K open‑market purchase of JCTC shares by an investment fund.

Market effects

none

none

none

Counterpoint

The small insider purchase is unlikely to move the stock.

Key entities

  • Jewett Cameron Trading Co Ltd

    Issuer of the shares purchased.

  • AJB Investment Fund II, LP

    Reporter of the insider transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).